| 
			  
			
 
  by Brandon Turbeville
 February 2013
 
			from
			
			BrandonTurbeville.Blogspot Website 
			  
			  
			  
			Updated excerpts from, 
			
			
			Codex Alimentarius - The End of Health Freed
 
			  
			  
			  
			  
			  
			
			
			Part 1 
			February 4, 2013 
			
 
			Over the last two years, I have written 
			extensively about the Codex Alimentarius guidelines and how they 
			relate specifically to
			
			vitamin and mineral supplements,
			
			food irradiation, and the use of
			
			Recombinant Bovine Growth Hormone (rBGH).
 I have also detailed the history and workings of the international 
			organization as well as many of the current day to day 
			manifestations of Codex guidelines as they appear in
			
			domestic policy.
 
 However, there is yet another area in which Codex guidelines will
			play a major role in the development of food policy - namely, 
			the proliferation of Genetically Modified Food.
 
 The Codex committee that serves as the main battleground for the 
			consideration of GM food is the Codex Committee on Food Labeling. 
			This committee is extremely relevant due to the fact that it can 
			effectively reduce the power of the consumer to virtually nothing if 
			it decides not to force companies or countries to label their GM 
			food, thus removing the ability of the consumer to boycott and/or 
			avoid those products.
 
			  
			While it is well-known that public sentiment 
			is unimportant to those at the top, governments and corporations 
			tend to pay more attention when votes and sales reflect that 
			sentiment. However, if Codex continues on its’ way to allowing 
			unlabelled GM food onto the international market, the repercussions 
			of consumer reaction will be entirely neutralized. 
 A brief discussion of the history of Codex in terms of GM food is 
			necessary here to understand the direction that the organization is 
			moving towards in regards to it.
 
 For most of the seventeen years that Codex member countries have 
			debated the safety of genetic modification of the food supply, the 
			result has been little or no progress for one side or the other.
 
 In 1993, at the behest of the Codex Commission, the CCFL agreed
			to begin working on the labeling aspect of GM food. 
			Interestingly enough, the CCFL asked the United States, the country 
			that was the most militant in its support of genetic modification, 
			to develop a paper that would guide the committee’s discussion at 
			the following session.
 
			  
			When this session arrived, there was a flurry 
			of opinions tossed around from several different countries.  
			  
			The most 
			sensible position was that all GM foods should be labeled under any 
			circumstances. Yet other countries, especially the pro-Gm ones, 
			argued that labeling should only be required when there is the 
			introduction of health or safety concerns, allergens, or when the 
			food is significantly different from its traditional counterpart.[1]
			   
			This is a debate that largely continues 
			until this day.
 The concept of “substantial equivalence” versus “process-based” 
			labeling has also become one of the most hotly contested issues 
			within the Codex GM food labeling debate. Process-based labeling 
			simply means that the driving factor behind the labeling guidelines 
			is the process by which the food is created, grown, or otherwise 
			produced.
 
			  
			Therefore, the qualifying factor for labeling GM food 
			would be the process of genetic modification itself, forcing all GM 
			food to be labeled as such. This is essentially the mandatory 
			labeling of all GM food. When this concept was first introduced in 
			2001, it was supported by such countries as the European Union, 
			India, and Norway.  
			  
			Its staunchest opponents, of course, were the 
			United States and Canada.[2]   
			  
			Although this method of labeling 
			standards was by far the most sensible if one were concerned about 
			food safety and consumer rights of choice, it has been all but 
			abandoned since the brief discussion at its introduction. The 
			attention then has necessarily turned to the competing set of 
			standards known as “substantial equivalence.”
 “Substantial equivalence” guidelines are by far the most onerous 
			means by which to label GM food outside of the scheme of voluntary 
			labeling (such as what Canada has already pushed for).[3]
 
 This set of standards not only provides loopholes through which GM 
			food may enter the food supply, but also opens the door to total 
			acceptance of GM food
			absolutely free of labeling. The idea behind the substantial 
			equivalence labeling method is that the GM food will be compared to 
			its conventional counterpart in terms of safety and composition.[4]
 
 The food would then only require a label if it was found that there 
			was a substantial difference between the GM product and the natural 
			food or there were an introduction of a common allergen through the 
			process of genetic modification.
 
			  
			While at first it may seem that 
			there is a legitimate consideration of safety under these 
			principles, such an impression is far from the truth. 
 Several problems exist with the concept of substantial equivalence. 
			First, as is often the case with government and bureaucratic 
			initiatives, the semantics of the term “substantial equivalence” 
			leaves the door open to the possible acceptance of virtually all GM 
			food.
 
			  
			While I will discuss this aspect further in future articles 
			where the accepted Codex guidelines for testing GM food is 
			mentioned, brief mention is still required early on in order to 
			understand the dangers of the use of this labeling standard.
 In order for a food to require labeling, it must do one of two 
			things - introduce a new allergen or be significantly different from 
			its “traditional counterpart.”[5]
 
			  
			The former requirement refers to 
			the introduction of something along the lines of the peanut gene or 
			the introduction of another common allergy to a food, thereby 
			causing a potential allergic reaction to the food after consuming 
			it.  
			  
			However, there are thousands of food allergies besides peanuts. 
			Codex itself admits in its GM food test protocol that the 
			determination of what may be an allergy is a very difficult 
			procedure.  
			  
			It says, 
				
				“At present, there is no definitive test that can 
			be relied upon to predict allergic response in humans to a newly 
			expressed protein.”[6]  
			Although the guidelines go on to say that these potential allergens 
			should be tested on a case-by-case basis, it is clear that the 
			testing mechanisms being recommended are not necessarily geared for 
			determining the potential allergenicity of newly introduced GM 
			foods.    
			Especially on the scale that is needed to deal with the 
			immense diversity of GM prototypes being introduced and the even 
			greater variety of individual allergies that exist in the 
			population. 
 It should also be noted that while there is some discussion of known 
			allergens, there is no in-depth discussion of the very real 
			possibility of new and previously unknown allergens being introduced 
			due to the process of genetic modification. Indeed, the monitoring 
			of the food once it enters the food chain is only occasionally 
			mentioned throughout the Codex “Foods Derived From Modern Biotechnology” document and those mentions are vague and 
			open-ended.[7]
   
			So the question that follows is whether or not all of 
			these potential allergens will be labeled as such, or if only the 
			most common ones will be considered. 
 Second, the requirement that a food must be compared and found 
			substantially equivalent to its “traditional counterpart” (natural 
			food) is misleading as well. To begin with, one must ask the 
			question of what exactly “substantial equivalence” means. Quite 
			obviously, the term does not mean that the GM product must be 
			identical.
   
			This, in itself would negate the process of genetic 
			modification. 
 Therefore, differences must necessarily be accepted. However, it is 
			not at all clear just to what level these differences may exist and 
			still be considered equivalent and/or safe. Nowhere is “substantial 
			equivalence” clearly defined. The criterion for what is substantial 
			and what is not is left completely open and subjective.
 
 The closest thing there is to a definition is made by Nick Tomlinson 
			of the UK Food Standards Agency in his report,
 
				
				“Joint FAO/WHO Expert Consultation 
				on Foods Derived from Biotechnology” where he references the 
				1996 expert consultation where substantial equivalence was 
				defined as “being established by a demonstration that the 
				characteristics assessed for the genetically modified organism, 
				or the specific food product derived there from, are equivalent 
				to the same characteristics of the conventional comparator.”
				[8] 
			Here again the term equivalence 
			is used with the connotation that equivalent does not translate into 
			identical or same.    
			Tomlinson makes this clear when he says: 
				
				The levels and variation for 
				characteristics in the genetically modified organism must be 
				within the natural range of variation for those characteristics 
				considered in the comparator and be based upon an appropriate 
				analysis of data.[9]
				 
			By not exactly being descriptive as to 
			how wide a range this “natural range of variation” may be, it is 
			apparent that substantial equivalence does not correlate to 
			identical or even anything that would remotely be considered the 
			“same.”  
			  
			Indeed, the very nature of genetic modification precludes 
			this as a possibility to begin with. 
 The concept of substantial equivalence is unfortunately the theory 
			of labeling requirements adopted by Codex. It is also very similar 
			to the criteria used in the United States and Canada.
 
 As to be expected in such pro-GM countries as the United States, the 
			GM labeling requirements are even less restrictive than those of 
			Codex. For the most part, labeling of GM foods in the United States 
			and Canada is completely voluntary.
 
 This voluntary labeling scheme based on the concept of substantial 
			equivalence is both a prime example of the weakness of both 
			standards as well as a dark omen as to the direction of Codex 
			guidelines as they continue to be developed.[10]
 
     
			Sources
 
				
				[1] MacKenzie, Anne. A. “The Process 
				of Developing Labeling Standards For GM Foods In The Codex 
				Alimentarius.” AgBioForum, Vol.3, Number 4, 2000. pp. 203-208.
				
				http://www.agbioforum.org/v3n4/v3n4a04-mackenzie.htm 
				Accessed May 24, 2010. [2] “Canadians Deserve To Know What They Are Eating: Food Safety 
				Must Come Before Trade.” Canadian Health Coalition, Media 
				Advisory, May 1-4, 2001.
				
				http://www.healthcoalition.ca/codex.html
 [3] Ibid.
 [4] “Safety aspects of genetically modified foods of plant 
				origin, a joint FAO/WHO consultation on foods derived from 
				biotechnology, Geneva, Switzerland 29 May - 2 June 2000”. World 
				Health Organization.
				
				http://www.who.int/foodsafety/publications/biotech/ec_june2000/en/index.html
 [5] MacKenzie, Anne. A. “The Process of Developing Labeling 
				Standards For GM Foods In The Codex Alimentarius.” AgBioForum, 
				Vol.3, Number 4, 2000. pp. 203-208.
				
				http://www.agbioforum.org/v3n4/v3n4a04-mackenzie.htm May 24, 
				2010.
 [6] “Food Derived From Modern Biotechnology.” Codex Alimentarius 
				2nd Edition. P.20
 
				[7] Ibid. [8] Tomlinson, Nick. “Joint FAO/WHO Expert Consultation on Foods 
				Derived from Biotechnology.” 2003.
				
				ftp://ftp.fao.org/es/esn/food/Bio-03.pdf Accessed May 24, 
				2010.
 [9] Ibid.
 [10] “Guidance For Industry: Voluntary Labeling Indicating 
				Whether Foods Have or Have Not Been Developed Using 
				Biotengineering: Draft Guidance.” Food and Drug Administration. 
				January 2001.
				
				http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/ucm059098.htm
 
			
 
           
			
			
			Part 2 
			February 6, 2013
   
			In my last above article, I 
			discussed the Codex Alimentarius position on the proliferation of 
			Genetically Modified food in the world’s food supply - particularly 
			the concept of
			substantial equivalence which uses circular and faulty logic in 
			order to allow greater saturation of the food supply with 
			genetically modified food.
 “Substantial equivalence,” is an approach that seeks to approve the 
			use and consumption of GM food based upon the idea that it is 
			“substantially equivalent” to its traditional counterpart, thus, GM 
			proponents claim, it is safe to consume and requires no extra 
			labeling.
 
			  
			This approach to GM food is easily dismantled and I 
			encourage the reader to
			access my article on the subject in order to understand the 
			weaknesses and dangers of using the substantial equivalence model 
			for GM food in any context.
 The concept of substantial equivalence is unfortunately the theory 
			of labeling requirements adopted by Codex. It is also very similar 
			to the criteria used in the United States and Canada. As to be 
			expected in such pro-GM countries as the United States, the GM 
			labeling requirements are even less restrictive than those of Codex.
 
 For the most part, labeling of GM foods in the United States and 
			Canada is completely voluntary.
 
			  
			This voluntary labeling scheme based 
			on the concept of substantial equivalence is both a prime example of 
			the weakness of both standards, as well as a dark omen as to the 
			direction of Codex guidelines as they
			continue to be developed.[1]
 The FDA does not require GM foods to be labeled unless they meet one 
			of four rather severe criteria. Even then, the labeling refers only 
			to the issue at hand, not the process from which the food was 
			created.
   
			The criteria for labeling are as 
			follows: 
				
					
					
					If a bioengineered food is 
					significantly different from its traditional counterpart 
					such that the common or usual name no longer adequately 
					describes the new food. 
					
					If an issue exists for the food 
					or a constituent of the food regarding how the food is used 
					or consequences of its use, a statement must be made on the 
					label to describe the issue. 
					
					If a bioengineered food has a 
					significantly different nutritional property, its label must 
					reflect the difference. 
					
					If a new food includes an 
					allergen that consumers would not expect to be present based 
					on the name of the food, the presence of that allergen must 
					be disclosed on the label.[2] 
			So, as these recommendations suggest, a 
			GM food must only be labeled when it is so different from its 
			“conventional counterpart” that it cannot even be considered the 
			same food, is the cause of reactions or consequences that the 
			natural version of it would not have caused, has a “significant” 
			difference in nutritional composition, or if it introduces an 
			allergen that would not otherwise have been present.
 It should be noted, like the Codex guidelines for substantial 
			equivalence mentioned earlier, that “significant” difference in 
			nutritional composition is not clearly defined. So what some may 
			consider to be truly significant might not even be considered worthy 
			of any concern by the FDA, and certainly not by the manufacturing 
			company.
 
 Also, as mentioned earlier, there is no discussion of whether or not 
			the inclusion of allergens to a food includes those less
			common allergies or just the most popular such as peanuts. Yet 
			even meeting these criteria does not necessarily draw the label of 
			“genetically modified” - merely a labeling of the potential side 
			effects of consuming these foods.[3]
 
 Only when one of these four criteria has been met must companies 
			label their products in a manner that may suggest genetic 
			modification and, even then, only in a subtle manner. In all other 
			instances, however, the labeling is completely voluntary.
 
 Just as disconcerting as voluntary labeling is the fact that the 
			alleged “safety testing” is not even conducted by the FDA or any 
			other regulatory agency, but by the food producers themselves. The 
			FDA merely takes for granted the truth of whatever is provided them 
			by industry. That is, if anything is provided to them at all.[4]
 
 As stated in the federal
			register as far back as 1992, the FDA says,
 
				
				FDA has traditionally encouraged 
				producers of new food ingredients to consult with FDA when there 
				is a question about an ingredient’s regulatory status, and firms 
				routinely do so, even though such consultation is not legally 
				required.[5] 
			It is certainly concerning to know that, 
			at best, firms are encouraged to consult with the FDA but are not 
			required to do so. Interestingly enough, this is not the position 
			taken in regards to proven safe and effective natural and herbal 
			supplements. 
 Adding to absurdity of the voluntary labeling policy held by the 
			FDA, the regulatory agency works on the premise that GM foods are 
			safe to begin with and that there is no difference between GM food 
			and natural food.[6]
 
 In the 1992 FDA Federal Register, the agency makes the claim,
 
				
				In most cases, the substances 
				expected to become components of food as a result of genetic 
				modification of a plant will be the same as or substantially 
				similar to substances commonly found in food, such as proteins, 
				fats and oils, and carbohydrates.[7] 
			Notice the similar terminology of 
			“substantially similar” as compared with the “substantial 
			equivalence” of Codex.  
			  
			This adds even more credibility to the idea 
			that the Codex model of GM food regulation is based on that used by 
			the pro-GM FDA. Not only that, although the difference between the 
			wording might seem unimportant to some, the term “similar” is even 
			more open-ended than the Codex “equivalent.” 
 But how did the FDA come to these conclusions?
 
 The agency admits that there is no premarket testing by the FDA 
			itself; merely relying on industry to voluntarily consult with the 
			FDA only when the industry feels there might be a problem with the 
			product. [8]
 
 Yet the agency still maintains, through basic assumption, that GM 
			foods are not different from the natural versions. In the same 
			Federal Register it says,
 
				
				Under this policy, foods, such as 
				fruits, vegetables, grains, and their byproducts, derived from 
				plant varieties developed by the new methods of genetic 
				modification are regulated within the existing framework of the 
				act, FDA’s implementing regulations, and current practice, 
				utilizing an approach identical in principle to that applied to 
				foods developed by traditional plant breeding. 
				 
				  
				The regulatory 
				status of a food, irrespective of the method by which it is 
				developed, is dependent upon objective characteristics of the 
				food and the intended use of the food (or its components). 
				 
				  
				The 
				method by which food is produced or developed may in some cases 
				help to understand the safety or nutritional characteristics of 
				the finished food. 
				 
				  
				However, the key factors in reviewing safety 
				concerns should be the characteristics of the food product, 
				rather than the fact that the new methods are used.[9]
				 
				 
			The FDA here is claiming that the 
			process of genetic modification, even though it has not evaluated it 
			thoroughly, is not only safe but, for the most part, irrelevant to 
			the question of food safety. 
 Of course, this is merely manufacturing conclusions out of thin air. 
			The FDA asserts the safety of GM food because there is “substantial 
			equivalence” between the two. However, there is “substantial 
			equivalence” only because the FDA claims that this is the case. 
			There is a massive lack of evidence to support any of these claims.
 
 The FDA also claims that genetic engineering is no different from 
			“traditional plant breeding,” an argument that is often made within 
			the pro-GM community. Such is the belief (or argument) that 
			traditional means of plant breeding such as grafting and 
			cross-pollination are essentially the same as removal and insertion 
			of DNA from one life form to another. In reality, nothing could be 
			further from the truth.
 
 This argument would be akin to claiming that breeding of humans of 
			different ethnic backgrounds is the same as breeding between humans 
			and horses. 
			Additionally, the question of how the FDA would know this - since 
			it has not conducted any scientific experiments regarding this claim 
			- arises yet again.
 
			  
			Still, it continues to blend the two very 
			different methods together by defining genetic engineering as the, 
				
				“alteration of the genotype of a plant using any technique, new or 
			traditional.” [10] 
			Thus, the FDA puts the insertion of a pig gene into a tomato into 
			the same category as natural birth, since genes change and develop 
			with each generation.  
			  
			If there were any doubt as to whether or not 
			this is the FDA’s position their claim that “Most, if not all, 
			cultivated food crops have been genetically modified,” should easily 
			remove it. [11]  
			  
			This claim is only true if one accepts the FDA’s 
			definition of natural reproduction as genetic engineering. 
 As in most cases involving the FDA, the biotech food industry, and 
			Codex Alimentarius, the boundaries of logic are not only pushed to 
			the breaking point in order to justify and promote the proliferation 
			of GM food, those boundaries are regularly crossed.
 
 Indeed, these mental gymnastics used create an environment in which 
			toxic GM food is virtually unregulated while healthy organic 
			substances are annihilated by force and regulation are a feat in 
			their own right.
 
     
			Sources
 
				
				[1] “Guidance For Industry: 
				Voluntary Labeling Indicating Whether Foods Have or Have Not 
				Been Developed Using Biotengineering: Draft Guidance.” Food and 
				Drug Administration. January 2001.
				
				http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/ucm059098.htm
				[2] Ibid.
 [3] Ibid.
 [4] “Statement of Food Policy - Foods Derived From New Plant 
				Varieties,” FDA Federal Register Vol. 57. 1992.
				
				http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/Biotechnology/ucm096095.htm 
				Accessed May 24, 2010.
 [5] Ibid.
 [6] Ibid.
 [7] Ibid.
 [8] Ibid. p. 5.
 [9] Ibid p. 4.
 [10] Ibid.
 [11] Ibid.
               
			
			
			Part 3 
			February 8, 2013
   
			In my last above article, “Codex 
			Alimentarius and GM Food Guidelines Pt. 2,” I wrote extensively 
			about the position assumed by the FDA in regards to genetically 
			modified food and the methodology used to assess its safety before 
			it is released into the general food supply.  
			  
			Needless to say, the 
			FDA, which is notorious for its corruption and
			
			revolving door with Big Agricultural Corporations
			
			like Monsanto, takes an unbelievably hands-off approach to the 
			regulation of GM food. 
 Yet, unfortunately, the approach taken by the FDA toward GM Food is 
			only unbelievable if one expects the agency to
			apply science, logic, and reason to their decision-making 
			process.
 
 However, when one begins evaluating the FDA position on GM food in 
			the context of the position held by Codex Alimentarius, one can 
			easily see an agenda taking shape whose ultimate goal is the total 
			proliferation of GM food the world over.
 
 For instance, in the early 1990s, around the time the FDA was 
			announcing its own policy toward GM food, the debate within Codex 
			was heating up as well. Most of the arguments were taken up by the 
			Codex Committee on Food Labeling (CCFL) and, for the most part, 
			pitted the United States and Canada against the European Union, 
			India, and Norway.
 
 In 1996, because little could be agreed upon, the CCFL asked for 
			guidance from the Codex Alimentarius Commission (CAC) on how 
			labeling guidelines might be developed. In 1997 the CAC produced a 
			document for that purpose.
 
			  
			These recommendations were that foods not 
			“equivalent” to natural foods in
			nutritional value, intended use, or composition should be 
			labeled.
 Yet this was not accepted into Codex guidelines as,
 
				
			 
			...in opposing these recommendations. 
			 
			  
			Definitions of terms also became 
			an issue at the meeting.[1]
 At the 27th CCFL session in 1999, it was decided that the Proposed 
			Draft Recommendations for GM food labeling be reconsidered and 
			rewritten. For this purpose, Codex created the Ad Hoc Working Group. 
			Their stated mission was to more fully define “biotechnology-derived 
			foods” and to revise the options considered for labeling between 
			process-based and substantial equivalence methods.
 
			  
			The Working Group 
			also agreed to consider establishing a maximum level of GM 
			ingredients in a food as well as a minimum level for accidental 
			inclusion of GM ingredients or food within a food. 
 As mentioned earlier, substantial equivalence has emerged as the 
			most favored method of labeling within Codex, in an almost identical 
			fashion to the FDA and
			Health Canada model.
 
 Indeed, it is easily understood why this is the case when one takes 
			a closer look at the Working Group developed to evaluate and rewrite 
			labeling recommendations. While certain instances may seem harmless 
			when viewed separately, when taken together they reveal a rather 
			obvious attempt to stack the odds in favor of pro-GM sentiment by 
			the CCFL.
 
 First, Canada, perhaps the most pro-GM Codex member country besides 
			the United States, was selected to chair the Group as well as 
			coordinate the Group’s direction.
 
 Also, a smaller Drafting Group was created under the Working Group 
			to “hold the pen.” It was this group that would do much of the 
			actual work in terms of hammering out the Recommendations document. 
			However, five of the six countries represented in the Drafting Group 
			were pro-GM countries.[2]
 
			  
			Clearly, it would be difficult for a 
			non-favorable view of GM food to
			win out in a situation such as this. 
 In 2000, an attempt was made by the CCFL to direct the Working Group 
			to streamline the two different methods of labeling (process-based 
			and substantial equivalence) into a Codex Guideline as well as other 
			key issues involving GM food labeling. A document of this nature was 
			subsequently produced by the United States. Yet, despite the packing 
			of the Drafting and Working Groups, the CCFL was still unable to 
			approve the guidelines that the groups produced.
 
 However, the Committee was able to approve the use of three 
			definitions related to GM food.[3]
   
			They are as follows: 
				
					
					
					Food and food ingredients 
					obtained through certain techniques of genetic 
					modification/genetic engineering - food and food ingredients 
					composed of or containing genetically modified/engineered 
					organisms obtained through modern biotechnology, or food and 
					food ingredients produced from, but not containing 
					genetically modified/engineered organisms obtained through 
					modern biotechnology. 
					
					Genetically modified/engineered 
					organism - an organism in which the genetic material has 
					been changed through modern biotechnology in a way that does 
					not occur naturally by multiplication and/or natural 
					recombination. 
					
					Modern Biotechnology - the 
					application of:  
				
					
						
						
						In vitro nucleic acid 
						techniques, including recombinant deoxyribonucleic acid 
						(DNA) and the direct injection of nucleic acid into 
						cells or organelles 
						
						Fusion of cells beyond the 
						taxonomic family, that overcome natural physiological, 
						reproductive, or recombination barriers and that are not 
						techniques used in traditional breeding and 
						selection.[4] 
			When one looks at the definitions agreed 
			upon at the 29th session of Codex, it can be seen that there is a 
			move toward using the term “modern biotechnology” in place of 
			“genetic engineering/modification.”  
			  
			This is largely an attempt to 
			use semantics in an effort to reduce, through ignorance, the 
			apprehension of the public to the consumption of GMO’s.
 However, in the face of such controversy, in 2003 Codex did produce 
			and approve a set of Guidelines for the assessment of the safety of 
			GM food. Entitled “Codex Principles and Guidelines On Foods Derived 
			From Biotechnology,” the Guidelines do not deal with labeling 
			concerns at all, but with the standards for the science used to 
			assess these foods for safety.
 
 The “Codex Principles and Guidelines On Foods Derived From 
			Biotechnology” is made up of four sections, two of which deal with 
			GM plants while the other sections deal with GM organisms in general 
			and GM animals respectively.
 
			  
			Similar to the “Guidelines for Vitamins 
			and Mineral Supplements,” these guidelines are not only unscientific 
			but carefully crafted to allow the approval of dangerous GM foods. 
			The game, in essence, is clearly rigged. 
 When looking at the first section of the guidelines one is able to 
			see a very real correlation to those designated for vitamins and 
			minerals. Using a form of risk analysis to determine the safety of 
			GM food, Codex seeks to explain the reason for its choice of 
			methodology.
 
			  
			It states, 
				
				While risk analysis has been used 
				over a long period of time to address chemical hazards (e.g. 
				residues of pesticides, contaminants, food additives and 
				processing aids), and it is being increasingly used to address 
				microbiological hazards and nutritional factors, the principles 
				were not elaborated specifically for whole foods.[5]   
			This is an interesting statement 
			considering the fact that risk analysis was indeed considered 
			adequate for the safety examination of vitamins, minerals, and 
			nutritional supplements. However, for whole foods, GM foods in 
			particular, Codex has decided that risk analysis is not appropriate.
			
 The very
			next section of the Introduction admits that while risk analysis 
			can in fact be applied to foods (including GM food) “in general 
			terms”,
 
				
				“it is recognized that this approach must be modified when 
			applied to a whole food rather than to a discrete hazard that may be 
			present in food.”[6]  
			One can gain an understanding of how the 
			process is adapted to suit the needs of Codex by reading through the 
			guidelines as a whole.  
			  
			However, suffice it to say that this 
			modification is generally the removal of all standards and 
			qualifications that might illuminate the vast amount of safety 
			concerns present within GM foods.[7]  
 Another disturbing statement made in the introduction to the 
			document casts even more doubt upon the scientific validity of 
			Codex’s guidelines.
 
			  
			The Guidelines state, 
				
				Where appropriate, the results of a 
				risk assessment undertaken by other regulatory authorities may 
				be used to assist in the risk analysis and avoid duplication of 
				work.[8]   
			While on its face, this statement 
			appears only to be a call for labor efficiency, at its best it 
			assumes the objectivity of the regulatory authorities doing the 
			testing.  
			  
			However, what is most concerning about this policy is that 
			risk assessment “conclusions” reached by regulatory agencies such as 
			the FDA and Health Canada may be accepted in place of an independent 
			examination. 
 Truthfully, the likelihood of a legitimately independent assessment 
			made possible by Codex is almost nonexistent.
 
			  
			However, in the case 
			of GMO’s, the odds are even less so for the FDA and Health Canada, 
			two agencies that have been largely bought and paid for by Monsanto 
			and other large agri-business corporations. Indeed, as far as GM 
			foods go, the FDA assessments have largely been completed since the 
			time that the agency has claimed that there is no difference between 
			genetic modification and traditional plant breeding.[9]  
			  
			This agency 
			has also made it clear that safety testing is to be conducted by the 
			manufacturer of the product rather than the agency itself, relying 
			solely on the company’s scientific and moral standards.  
			  
			In effect, 
			as mentioned earlier, the science determining the safety of GM foods 
			comes straight from the manufacturer itself.[10] 
 With this in mind, one can clearly see that the same line of 
			ascension exists in Codex Alimentarius. If Codex is willing to 
			accept the safety assessments of regulatory agencies without 
			independent testing of its own and regulatory agencies are willing 
			to accept the safety assessments of corporations without independent 
			testing of their own, then Codex is willing to accept the safety 
			assessments of corporations without independent safety testing of 
			their own.
 
			  
			Indeed, this syllogism adequately reflects the reality of 
			the relationship between Codex, corporations, and the future of GM 
			foods. 
 Another issue of great concern is the definition of “conventional 
			counterpart.” Because Codex uses the concept of substantial 
			equivalence[11], this seemingly requires that the GM product be 
			compared to its natural counterpart.
 
 However, the definition of conventional counterpart, according to 
			Codex, is,
 
				
				“a related organism/variety, its components and/or 
			products for which there is experience of establishing safety based 
			on common use as food.”[12]  
			This definition poses a potential 
			problem because it does not make clear (in the body of the text) 
			that the conventional counterpart must be the natural version of the 
			food. In a footnote, the statement is made that, 
				
				“It is recognized 
			that, for the foreseeable future, foods derived from modern 
			biotechnology will not be used as conventional counterparts.” [13]
				 
			The phrase, “for the foreseeable future” raises its own 
			difficulties, because it provides a potential loophole.  
			  
			“Foreseeable 
			future” does not set a timeline for the current policy to run out, 
			but it does leave open the possibility of allowing a change in the 
			current practice. 
 Allowing GM products to be compared to other GM products for 
			substantial equivalence is an enormous blow to the environment, 
			human health, and consumer choice. Such an action would completely 
			undercut the already weak and ridiculous method of substantial 
			equivalence and would turn the entire nature of our food supply 
			upside down.
 
			  
			One would be comparing a dangerous product to another 
			dangerous product but labeling it safe because it was substantially 
			equivalent to the first dangerous product. 
 Like the situation involving vitamins and minerals, this is the 
			Twilight Zone reality produced by Codex once it gains power of 
			the food supply.
 
     
			Sources
 
				
				[1] MacKenzie, Anne. A. “The Process 
				of Developing Labeling Standards For GM Foods In The Codex 
				Alimentarius.” AgBioForum, Vol.3, Number 4, 2000. pp. 203-208.
				
				http://www.agbioforum.org/v3n4/v3n4a04-mackenzie.htm May 24, 
				2010. [2] Ibid.
 Please Note:
 While it is true that the European Union had two representatives 
				on the panel, it also true that the EU speaks with one voice. 
				Even if one were to argue that this would give them extra 
				representation, pro-GM nations still outnumber anti-GM nations.
 [3] MacKenzie, Anne. A. “The Process of Developing Labeling 
				Standards For GM Foods In The Codex Alimentarius.” AgBioForum, 
				Vol.3, Number 4, 2000. pp. 203-208.
				
				http://www.agbioforum.org/v3n4/v3n4a04-mackenzie.htm May 24, 
				2010.
 [4] Ibid.
 [5] “Foods Derived From Modern Biotechnology,” 2nd edition. 
				Codex Alimentarius. P.1
 [6] Ibid.
 [7] Ibid.
 [8] Ibid.
 [9] “Statement of Food Policy - Foods Derived From New Plant 
				Varieties,” FDA Federal Register Vol. 57. 1992.
				
				http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/Biotechnology/ucm096095.htm 
				Accessed May 24, 2010.
 [10] Ibid.
 [11] “Foods Derived From Modern Biotechnology,” 2nd edition. 
				Codex Alimentarius. P. 9
 [12] Ibid. p.2
 [13] Ibid.
               
			
			
			Part 4 
			February 11, 2013  
			
 In my last above article regarding Codex Alimentarius Guidelines on 
			Genetically Modified food, I discussed the dangerous concept used by 
			both the international organization and the U.S. Food and Drug 
			Administration (FDA) known as substantial equivalence/substantial 
			similarity and how this method of comparison and evaluation can and 
			is being used to further the proliferation of GM food in the world’s 
			food supply.
 
 In discussing the method used to evaluate the safety of GM food, I 
			wrote,
 
				
				If Codex is willing to accept the 
				safety assessments of regulatory agencies without independent 
				testing of its own and regulatory agencies are willing to accept 
				the safety assessments of corporations without independent 
				testing of their own, then Codex is willing to accept the safety 
				assessments of corporations without independent safety testing 
				of their own.  
				  
				Indeed, this syllogism adequately reflects the 
				reality of the relationship between Codex, corporations, and the 
				future of GM foods. 
			Furthermore, in regards to the 
			“substantial equivalence” methodology mentioned above, I concluded 
			the article by stating, 
				
				Allowing GM products to be compared 
				to other GM products for substantial equivalence is an enormous 
				blow to the environment, human health, and consumer choice.  
				  
				Such 
				an action would completely undercut the already weak and 
				ridiculous method of substantial equivalence and would turn the 
				entire nature of our food supply upside down.  
				  
				One would be 
				comparing a dangerous product to another dangerous product but 
				labeling it safe because it was substantially equivalent to the 
				first dangerous product. 
			Like the situation involving
			vitamins and minerals, this is the Twilight Zone reality 
			produced by Codex once it gains power of the food supply.
 Unfortunately, this potential concern is now an imminent one because 
			Monsanto has in fact submitted an
			application for a GM corn called LY038. In its submission for 
			approval, Monsanto provided the regulators’ assessing the product 
			with information comparing LY038 with another GM corn product called 
			LY038 (-), another GM corn product.[1]
 
 True to form, in many of the pro-GM countries such as New Zealand, 
			Australia, Japan, Canada, the Philippines, and South Korea, the 
			LY038 corn was approved based upon the method of using a GM corn as 
			a conventional counterpart.[2]
 
			  
			The United States, being the most 
			open to GM food, and only requiring voluntary submission, has also 
			approved LY038 for cultivation.[3]
 Thankfully, 
			the Monsanto agenda stalled in the European Union, and 
			in 2009 Monsanto withdrew its application for the product in 
			Europe.[4] This is largely due to a small group of relatively 
			independent scientists from the Centre for Integrated Research in Biosafety (INBI) out of New Zealand who brought out many risks 
			evident from a close reading of the Monsanto application dossiers.
 
 As a result of their work, the European Food Safety Authority (EFSA) 
			requested additional research and safety data. That was all that was 
			needed in
			order to cause Monsanto to withdraw its application for LY038 
			use in Europe.[5]
 
 Monsanto claimed that the reason for the removal of its submission 
			purely economical and that,
 
				
				“although our preference would have been 
			to
			complete the EU approval of LY038, conducting further studies, 
			as requested [by the EFSA GMO Panel], can no longer be justified, in 
			view of the additional costs involved and the reduced commercial 
			interest in this product.” [6] 
			However, those who are aware of Monsanto’s track record have a 
			different take. In a statement made to Biosafety Information Centre, 
			Prof. Jack Heinemann, who led the INBI research team, summed up the 
			situation succinctly. 
				
				I personally don’t believe that the 
				withdrawal of LY038 from commercialization was a budget
				blow-out. Monsanto estimated that the street-value of LY038 
				was going to be US $1 billion/year.  
				  
				People are still feeding 
				corn to cows, chickens and pigs and corn is still being 
				converted to biofuel in the US. The price of corn is at 
				historical highs and is not expected to decrease. Do we really 
				believe that a market of $1 billion/year is too small for 
				Monsanto? I don’t... The major issue raise by EFSA was 
				Monsanto’s use of another GM product as a control in all its 
				safety studies.  
				  
				This violates both international food safety 
				testing guidelines and European rules. INBI was the first in the 
				world to point this out. FSANZ [Food Standards Australia New 
				Zealand] ignored it. EFSA didn’t. Monsanto pulled the product. 
				 
				  
				We estimate that upwards of US $1 billion had already been 
				invested and if it were just a matter of demonstrating that a 
				safe product was safe, then a few tidy up scientific studies 
				would have cost nothing in comparison.[7] 
			The obvious reason that the application 
			was pulled, at least according to this writer and, seemingly, Prof. 
			Heinemann, is that Monsanto’s LY038 was absolutely unsafe for 
			consumption and that it would never have stood up to any scientific 
			safety testing. 
			  
			It is also likely that the company’s own research 
			data would have proven its danger since it would not even submit the 
			requested material to EFSA. In conjunction with this, Monsanto may 
			have been afraid that exposure of this fact would have crippled its 
			progress with the countries that did approve LY038.
 However, while it did not succeed with the EU (this time), the 
			precedent has been set for using a GM product as a conventional 
			counterpart.
 
 This will undoubtedly affect Codex guidelines in the future, 
			especially considering the fact that so many and such major players 
			have accepted these standards of testing. Indeed, it will 
			undoubtedly set a dangerous precedent for the evaluation of the 
			safety of GM food the world over.
 
     
			Notes
 
				
				[1] “New Attack on GM Food Safety 
				Testing Standards,” Centre for Integrated Research in Biosafety, 
				University of Canterbury. February 2007.
				
				http://www.sustainabilitynz.org/docs/Backgrounder_NewAttackonGMFoodSafetyStandards.pdf 
				Accessed May 24, 2010.[2] “Monsanto pulls GM corn amid serious food safety concerns,” 
				GM Free CYMRU.
				
				http://gmfreecymru.org/Press_Notice9Nov2009.htm
 [3] “Transgenic high-lysine corn LY038 withdrawn after EU raises 
				safety questions,” The Bioscience Resource Project, Nov. 10, 
				2009.
				
				http://www.bioscienceresource.org/news/article.php?id=43 
				Accessed May 24, 2010.
 [4] “Europe balks at GE corn in NZ,”
				Stuff.co.nz, Feb. 11, 2009.
				
				http://www.stuff.co.nz/national/3020246/Europe-balks-at-GE-corn-in-NZ
 [5] “Monsanto pulls GM corn amid serious food safety concerns,” 
				GM Free CYMRU.
				
				http://gmfreecymru.org/Press_Notice9Nov2009.htm
 [6] “What has happened to high lysine corn?” Biosafety 
				Information Centre.
				
				http://www.biosafety-info.net/bioart.php?bid=583&ac=st
 [7] Ibid.
               
			
			
			Part 5 
			February 15, 2013     
			In my last article, “Codex 
			Alimentarius and GM Food Guidelines Pt.4,” I discussed a 
			tangible, real-world example of the results of using “substantial 
			equivalence” or “substantial similarity” when assessing the dangers 
			of Genetically Modified (GM) food and/or approving that food for the 
			market.
 
			Returning to the defining Codex document 
			in relation to GM food, “Food Derived From Modern Biotechnology,” 
			it should be noted that the risks associated with GMOs are dealt 
			with in a rather curious manner.   
			Indeed, the monitoring and management of 
			risks from GM food after their approval is mentioned rather blandly 
			in the introductory section of the Guidelines.    
			It says,
 
				
					
					Post market-monitoring may be 
					undertaken for the purpose of:  
						
						A) Verifying conclusions 
						about the absence or the possible occurrence, impact and 
						significance of potential consumer health effects; and
						 
						
						B) Monitoring changes in 
						nutrient intake levels, associated with the introduction 
						of foods likely to alter nutritional status 
						significantly, to determine their human health impact.
						[1] 
				It should be noted that these are 
				issues which should be resolved in a scientific setting prior to 
				market.    
				Yet Codex is obviously content to 
				allow the public to act as lab rats in the real world rather 
				than force these side effects to be addressed in an actual lab. 
				Absolute disregard for the global population is evident here.
				 
			As will be discussed in future articles, when one understands the 
			ultimate purpose of Codex Alimentarius, it becomes clear as to why 
			policies like this emanate from the organization. Such is also the 
			case when Codex mentions the management of risks finding their way 
			into the market and the need for post-market tracing for the purpose 
			of recall.[2]
   
			It is important to note that tracing 
			food materials is a difficult task, especially if those products 
			have already found their way into the environment and have begun to 
			reproduce.
 
				
				
					
					The Codex principles of risk 
					analysis, particularly those for risk assessment, are 
					primarily intended to apply to discrete chemical entities, 
					such as food additives and pesticide residues, or a specific 
					chemical or microbial contaminant that have identifiable 
					hazards and risks; they are not intended to apply to whole 
					foods as such.[3] 
				Essentially, this is an admission 
				that risk assessment methodology is absolutely incapable and 
				inappropriate when dealing with the safety of a whole food.
				   
				As Codex makes clear, the principles 
				for risk assessment were never intended to address anything 
				other than chemicals and additives.
 However, one should remember that risk assessment is indeed the 
				method used to determine the safety of vitamins, nutrients, and 
				minerals by Codex Alimentarius in order to label them unsafe at 
				unreasonably low levels.
 
 But Codex continues with even further admission that the testing 
				methods used are not nearly as intense as one might think.
   
				The document reads, 
					
					Traditionally, new varieties of 
					food plants have not been systematically subjected to 
					extensive chemical, toxicological or nutritional evaluation 
					prior to marketing, with the exception of foods for specific 
					groups, such as infants, where the food may constitute a 
					substantial portion of the diet.    
					Thus, new varieties of corn, 
					soybean, potatoes and other common food plants are evaluated 
					by breeders for agronomic and phenotypic characteristics, 
					but generally, foods derived from such new plant varieties 
					are not subjected to the rigorous and extensive food safety 
					testing procedures, including studies in animals, that are 
					typical of chemicals, such as food additives or pesticide 
					residues, that may be present in food.[4] 
				Simply put, Codex is admitting, 
				albeit cleverly, that the testing method for whole foods is 
				inadequate, and that the testing itself is not nearly as 
				extensive as it would be for evaluating a known toxin like a 
				chemical, pesticide, or apparently, vitamins and minerals.
 As related to Codex’s position on vitamins and minerals, Codex 
				considers genetically modified foods that have been engineered 
				to produce a deadly chemical or pesticide to be a whole food, 
				but vitamin C is considered a toxin.
 
 Yet Codex does not stop here with the prefacing of their 
				intended deceit and the admission of flawed and manipulated 
				science.
   
				It says, 
					
					Animal studies cannot be readily 
					applied to testing the risks associated with whole foods, 
					which are complex mixtures of compounds, often characterized 
					by a wide variation in composition and nutritional value.
					   
					Owing to their bulk and effect 
					on satiety, they can usually only be fed to animals at low 
					multiples of the amounts that might be present in the human 
					diet.   
					In addition, a key factor to 
					consider in conducting animal studies on foods is the 
					nutritional value and balance of the diets used; this is in 
					order to avoid the induction of adverse effects that are not 
					related directly to the material itself.    
					Detecting any potential adverse 
					effects and relating these conclusively to an individual 
					characteristic of the food can, therefore, be extremely 
					difficult. If the characterization of the food indicates 
					that the available data are insufficient for a thorough 
					safety assessment, properly designed animal studies could be 
					requested on the whole foods.    
					Another consideration in 
					deciding the need for animal studies is whether it is 
					appropriate to subject experimental animals to such a study 
					if it is unlikely to give rise to meaningful information.[5] 
				But there are several problems with 
				this statement.
 First, let it be made clear that this writer does not support 
				the use of animals for laboratory testing for any reason.
 
 However, this issue is not the focus of this article and it will 
				be repeatedly referred to in its proper context in terms of 
				scientific debate.
 
 That being said, what Codex has admitted to in this statement, 
				albeit subtly, is that test subjects will actually be fed 
				significantly less of the GM food in question than exists in the 
				standard human diet.
   
				Nowhere does Codex mention that the 
				amount fed to the test subjects can be adjusted per capita, but 
				simply that the amount fed to them will be, 
					
					“at low multiples of the amounts 
					that might be present in the human diet.” [6] 
				Furthermore, Codex attempts to 
				convince the reader that because of differences in nutritional 
				values and diet balance in the animals being tested it is 
				extremely difficult to determine if there are any adverse 
				effects resulting from the material being tested or another 
				material/condition. Hence, Codex would have the reader believe 
				that this problem could not be solved by the addition of a 
				control group.
 In the end, the overall conclusion of Codex is that testing GM 
				foods is largely unproductive and that, for the most part, it 
				should only be conducted in very special circumstances. Mere 
				post-market tracking is looked upon as the most favorable route.
   
				This, however, leaves the consumer 
				as the test subject, and corrective action can only be taken 
				after it is too late for hundreds, thousands, or even millions 
				of people.
 Codex furthers this claim with an admission of its acceptance of 
				“substantial equivalence” as a testing standard.
   
				Because of the problems associated 
				with using risk assessment to address dangers in whole foods 
				(but evidently not nutrients and vitamins), Codex claims it must 
				rely on substantial equivalence to address intended and 
				unintended changes in the food. Hence, Codex officially accepts 
				the concept. [7]
 In subsequent sections, Codex claims that even weak standards 
				like substantial equivalence may not be required.
   
				The guidelines state, 
					
					“For the reasons described in 
					Section 3, conventional toxicology studies may not be 
					considered necessary where the substance or a closely 
					related substance has, taking into account its function and 
					exposure, been consumed safely in food.” [8] 
				However, there is no discussion of 
				exactly how it will be determined that these substances have 
				been consumed safely in food to begin with.    
				Considering the fact that toxic 
				substances like fluoride and rBGH have been consumed “safely” in 
				food for many years, it is certainly frightening to think that 
				even more substances may be created and added to the food supply 
				under the guise of a history of safe consumption.    
				Nevertheless, this process (or lack 
				thereof) is not only unscientific, it is very dangerous. 
			Although Codex clearly maintains a double standard in regards to GM 
			food versus vitamins and nutrients, there are some similarities in 
			the risk assessment procedure applied to them. One of the few 
			instances in which Codex applies the same standards for GM food as 
			for dietary supplements is the area of nutritional properties of the 
			food.
 
 In fact, this procedure is in direct correlation to the Guidelines 
			for Vitamin and Mineral Food Supplements and works in tandem with 
			them in order to create a lower acceptable level of nutrients in the 
			food itself.
 
 In relation to this situation, it is important to pay close 
			attention to several statements made within the guidelines.
   
			For instance,
 
				
					
					Information about the known 
					patterns of use and consumption of a food, and its 
					derivatives should be used to estimate the likely intake of 
					the food derived from the recombinant-DNA plant.    
					The expected intake of the food 
					should be used to assess the nutritional implications of the 
					altered nutrient profile both at customary and maximal 
					levels of consumption.    
					Basing the estimate on the 
					highest likely consumption provides assurance that the 
					potential for any undesirable nutritional effects will be 
					detected. [9] 
				While this language is carefully 
				crafted to appear benign and concerned only with the welfare of 
				different cultures consuming the GM food, what is actually being 
				presented is the idea of a Global Expectable Average Daily Diet 
				for purposes of creating an Upper Limit not on GM food, but on 
				the nutrients existing within the food itself - all this, while, 
				at the same time, allowing genetically engineered food to remain 
				virtually unregulated.
 As mentioned in the chapter dealing with vitamin and mineral 
				supplements, the Global Average Daily Diet is simply taking the 
				“average” level of consumption of a food or nutrient across the 
				world and using that level as a base level standard for what 
				will be considered the average intake of the product by all 
				populations. The highest or lowest levels are usually chosen 
				based on the needs of the scientist, particularly in situations 
				like these where researchers have ulterior motives.
 
 Remember, in the case of vitamin and mineral food supplements 
				where the highest level of intake was used instead of the real 
				average. This was because third world countries were not 
				included properly in the average.
 
 Like the GADD for vitamins and nutrients, the highest level of 
				consumption will be used to examine GM food. However, using the 
				highest level of consumption, in this case, will have an 
				entirely different effect than it did upon vitamins and 
				minerals.
 
 Using the highest level of consumption estimation in concert 
				with the concept of substantial equivalence, Codex creates an 
				environment where it would be difficult for GM food not to be 
				approved.
 
 With the concept of substantial equivalence and the GADD taken 
				in concert with one another, we could easily imagine a 
				hypothetical scenario such as the following:
 
					
					We might imagine that potatoes 
					have a higher consumption rate in North America and Europe 
					than in other regions of the world. So researchers would 
					determine, based on the rate of potato consumption of Europe 
					and North America, the Global Expectable Average Daily Diet.
					   
					This average consumption rate 
					would be applied worldwide regardless of other cultures’ 
					consumption of potatoes. Likewise, using the concept of 
					substantial equivalence, GM potatoes would be approved with 
					an Upper Limit of the highest rate of consumption worldwide. 
			Thus, substantial equivalence and the 
			GADD are two pieces of the puzzle used to craft a system of 
			regulations in which vitamins and mineral supplements are severely 
			restricted in terms of levels of nutrition, while GM food remains 
			virtually unregulated at all. 
				
					
					In future articles, I intend to expand upon the 
					possibilities of these concepts to be used to form a 
					regulatory structure in which nutrition itself is regulated 
					even out of food and where the genetically modified version 
					is the only acceptable product.
         
			Over the last few weeks, I have written 
			a number of articles dealing with the dangers of the methods of 
			analyzing the risks of
			
			Genetically Modified (GM) food used 
			by both Codex Alimentarius and the FDA known as “substantial 
			equivalence/substantial similarity” and the “risk 
			assessment methodology used in the evaluation process.
			   
			In conjunction with the Codex document “Foods Derived From Modern Biotechnology,” 
			the Codex position on the 
			evaluation and labeling of GM food, I described the 
			hypocrisy of Codex’s position towards vitamin and mineral 
			supplements and its position in regards to GM food which is, 
			interestingly enough, one hundred and eighty degrees different.
 
 
 
				
				However, there are even
				more dangers 
				to using the “substantial equivalence/substantial similarity” 
				model in conjunction with the “risk assessment” evaluation 
				methodology in terms of GM food. 
				Indeed, there exists a very real possibility that the Codex 
				position on GM food as well as
				
				vitamin and mineral supplements will be used to develop a 
				food system in which GM food is the only acceptable form of food 
				allowed in the supply, while any other food may be removed from 
				the market.
   
				In addition, it is entirely possible 
				that once the standards are set by Codex and agreed upon by 
				nations participating in the WTO, that foods containing high 
				levels (or reasonable levels) of nutrition could be removed from 
				the market simply on the basis of their high nutritional 
				content. 
				
				For instance, the damage to the food supply does not end with 
				the introduction of GM foods. In addition, because Codex 
				standards are enforced by the WTO, the Maximum Permitted Levels 
				for vitamin and minerals developed by Codex will remain in 
				place.
 
 So, because the risk assessment for GM food based on 
				“substantial equivalence” will inevitably determine the GM food 
				itself to be safe, the problem then becomes the nutritional 
				value within the food.
 
 The nutrition then becomes the enemy and must be removed.
 
				
				While this might seem both improbable and impossible, it is, in 
				fact, neither.
 
 The seeming improbability of a Codex declaration of nutrients as 
				toxins has already been realized and the genetic manipulation of 
				the nutritional properties of food is not an impossibility at 
				all.
 
 While the cover story for the introduction of GM food often 
				involves the alleged wish to bring about the end of malnutrition 
				by increasing nutritional properties of the food genetically (a 
				blatant contradiction if one accepts that nutrients should be 
				treated as toxins), the ability to decrease nutrition through 
				genetic modification is just as realistic.
 
 We then have a situation where nutritionally deficient GM food 
				is not only allowed, but required due to the “dangerous” amount 
				of vitamins and minerals that exist in the natural food.
   
				Codex even admits later on in the 
				Guidelines that nutrients will be focused on rather than the 
				dangers of the GM food.   
				It says, 
					
					To assess the safety of a food 
					derived from a recombinant-DNA plant modified for a 
					nutritional or health benefit, the estimated intake of the 
					nutrient or related substance in the population(s) is 
					compared with the nutritional or toxicological reference 
					values, such as upper levels of intake, acceptable daily 
					intakes (ADIs) for that nutrient or related substance.[1] 
				The question then is not the safety 
				of the GM food, but of the amount of vitamins and nutrients 
				included in it.
 Continuing through the Guidelines, such a statement is cleverly 
				made.
   
				It says,  
					
					“Rather than trying to identify 
					every hazard associated with a particular food, the 
					intention of a safety assessment of food derived from 
					recombinant-DNA is the identification of new or altered 
					hazards relative to the conventional counterpart.” [2]
					 
				Not only is this an extremely 
				limiting set of standards for assessing the safety of the 
				product, what is actually meant by “hazard”, although not 
				explicitly stated, is nutrients.
 This is made even clearer in the next paragraph which states,
 
					
					“Upper levels of intake for many 
					nutrients that have been set out by some national, regional 
					and international bodies may be considered, as appropriate. 
					The basis for their derivation should also be considered in 
					order to assess the public health implications of exceeding 
					these levels.” [3]  
				Clearly, nutrients are the focus of 
				much of the risk assessment methods applied to GM food.
 This may initially cause some GM food products to be rejected by 
				Codex due to the higher level of nutritional properties being 
				produced. That is, until the food is modified once again to have 
				a lower nutritional value. When seen in this light, it becomes 
				obvious that many of the Codex Guidelines are intertwined with 
				one another.
   
				However, none are more important 
				than those related to vitamins, minerals, and nutrients.
 Returning to the Codex Guidelines themselves, the organization 
				leaves itself yet another loophole by claiming that, in a 
				situation where even the unbelievably weak “substantial 
				equivalence” method cannot allow the approval of a GM food, that 
				the food used as a conventional counterpart may be changed in 
				order to suit the GM product which is being evaluated.
   
				It says, 
					
					When the modification results in 
					a food product, such as vegetable oil, with a composition 
					that is significantly different from its conventional 
					counterpart, it may be appropriate to use additional 
					conventional foods or food components (i.e. foods or food 
					components whose nutritional composition is closer to that 
					of the food derived from recombinant-DNA plant) as 
					appropriate comparators to assess the nutritional impact of 
					the food.[4] 
				In this statement Codex is openly 
				admitting that it will simply change the “scientific” process 
				that we are supposed to put our faith in, in order to 
				accommodate the GM substance being tested.    
				Essentially, Codex is saying, 
				 
					
					“If the conventional counterpart 
					is not substantially equivalent, change the conventional 
					counterpart to one that is.” 
				Clearly, inasmuch as Codex 
				guidelines are accepted, Codex is exercising control over the 
				food supply and the choice that every human being has a right to 
				make on their own.    
				Unfortunately, it is a very real 
				possibility that if Codex Alimentarius is not stopped, we will 
				live in a much smaller world where starvation, sickness, and 
				hunger are rampant and where we must beg our multinational 
				corporate masters for a bite of the toxic mass that we will have 
				no choice but to eat.
 
   
				Sources
 
					
					[1] “Foods Derived From Modern Biotechnology,” 
					2nd edition. Codex Alimentarius. P.27 [2] Ibid. p.25
 [3] Ibid.
 [4] Ibid. p.17
               
				
				
				Part 7 
				February 20, 2013     
				In several of my recent articles, I 
				have discussed the 
				problems of using “risk 
				assessment” methodology in the evaluation of both 
				vitamin and mineral supplements and Genetically Modified (GM) 
				food.    
				I have also discussed at length the
				dangers of 
				the Codex Alimentarius and U.S. Food and Drug Administration 
				position on GM food which is known as “substantial 
				equivalence” and, in its more extreme forms, 
				“substantial similarity.”
 However, another concern addressed by the Codex Guidelines has 
				to deal with antibiotic resistance created through the process 
				of genetic engineering. Yet, as is typical of any Codex 
				Alimentarius presentation, the agency makes several misleading 
				and unsettling statements in this regard as well.
   
				While Codex does state that methods 
				should be used that do not result in antibiotic resistance, it 
				qualifies that claim in its document “Foods Derived From Modern Biotechnology,” 
				by stating that these methods should be used, 
					
					“where such technologies are 
					available and demonstrated to be safe.” [1] 
					 
				This is certainly no mandate. It is 
				merely a suggestion that will most likely be completely ignored 
				by industry.
 The Guidelines then go on to say that,
 
					
					“Gene transfer from plants and 
					their food products to gut micro-organisms or human cells is 
					considered a rare possibility because of the many complex 
					and unlikely events that would need to occur consecutively.” 
					[2]  
				This statement stands in direct 
				contradiction to established science.[3]    
				Indeed, the series of events that 
				would have to transpire in order for the transfer of modified 
				genes from a plant to human DNA or cells are neither unlikely 
				nor rare.   
				In a footnote to this statement, 
				Codex makes the claim, 
					
					“In cases where there are high 
					levels of naturally occurring bacteria that are resistant to 
					the antibiotic, the likelihood of such bacteria transferring 
					the resistance to other bacteria will be orders of magnitude 
					higher than the likelihood of transfer between ingested 
					foods and bacteria.” [4]  
				Yet while this may in fact be true 
				the statement is still misleading.    
				The issue being discussed in the 
				footnoted statement is the likelihood of DNA transfer from GM 
				plants to humans. Furthermore, if such events were so unlikely, 
				why would it be important not to use antibiotic resistant gene 
				technology in the future?
 Another concern presented in the section of “Foods Derived From 
				Moderin Biotechnology” dealing with GM plants is the question of 
				potential allergens being created within the food products as 
				well as the introduction of entirely new allergens that have 
				never before existed in nature.
 
 While Codex claims that “all newly expressed proteins” as well 
				as “a protein new to the food supply” should be tested for 
				safety, there are legitimate questions as to whether or not 
				Codex has the ability or the desire to test for such 
				possibilities. [5]
 
 First, while it is quite possible to know what foods occurring 
				naturally are allergenic, it is much more difficult to come to 
				these conclusions about new substances or proteins.
   
				This is partly due to the fact that 
				naturally occurring materials have so many millions of years of 
				history and use which, in itself, tends to naturally weed out 
				the allergenic foods from the non-allergenic ones in a 
				population’s diet. GM products do not have this history.
 Indeed, the idea that over time a population tends to form its 
				own guidelines through natural process adds to the ease in which 
				scientific inquiry may form knowledge of the food properties in 
				relation to the population itself. Again, this is not the case 
				with GM food.
 
 Therefore, another problem with the Codex Guidelines is made 
				manifest. Because Codex works on a global scale, the potential 
				allergens are listed globally and may not take into 
				consideration (in future labeling) the geographic concerns of 
				individual populations.
   
				When one considers the fact that 
				allergens differ across geographic boundaries, with some foods 
				being allergenic in one culture but not in others, he/she is 
				confronted with the task that, in order to introduce a new 
				substance into the food supply with new proteins, all of these 
				populations must be tested separately.    
				The tests of course should also be 
				conducted over a longer period of time to investigate prolonged 
				exposure.
 However, Codex makes no mention of this problem and, likewise, 
				mentions no remedy for it.
   
				Are we really supposed to believe 
				that, hidden deep within the Guidelines, Codex plans to organize 
				representative samples of every culture across the globe for 
				every new protein added to the food supply? This is not likely 
				even if one believed the organization was working truly 
				promoting food safety.
 Secondly, Codex itself admits tremendous flaws in its ability to 
				test for new allergens.
   
				It says quite plainly that, 
					
					“there is no definitive test 
					that can be relied upon to predict allergic response in 
					humans to a newly expressed protein.” [6] 
					 
				Because of this lack of a 
				standardized and easily deciphered test, it goes on to say, 
					
					“A critical issue for testing 
					will be the availability of human sera from sufficient 
					numbers of individuals.” [7]  
				This, however, is a major problem 
				due to the fact that in order to test for just one allergy a 
				minimum of eight sera is required for a major allergy, and a 
				minimum of twenty-four sera for a minor allergy.[8]
 This is a rather large amount of material for testing purposes. 
				It should be noted that this is the required sera for just one 
				test subject. This test would have to be repeated hundreds and 
				perhaps even thousands of times per geographic region or 
				culture. It would then have to be replicated hundreds or 
				thousands of times more on a global scale to account for these 
				regions and cultures.
 
 Even Codex admits, albeit in a footnote, that,
 
					
					“It is recognized that these 
					quantities of sera may not be available for testing 
					purposes.” [9] 
				With this in mind, it is clear that 
				testing for allergens in GM products would prove extremely 
				difficult to organize and conduct, even if Codex were truly 
				committed to its professed goal of food safety.         
				Notes 
					
					[1] “Foods Derived From Modern Biotechnology,” 
					2nd edition. Codex Alimentarius. P.18 [2] Ibid. p.18
 [3] Ho, Mae-Wan; Ryan, Angela; Cummins, Joe; “Cauliflower 
					Mosiac Viral Promoter- A Recipe For Disaster?” 
					Institute of Science in Society.
 [4] Foods Derived From Modern Biotechnology,” 2nd edition. 
					Codex Alimentarius. P.18
 [5] Ibid. p. 27
 [6] Ibid. P.20
 [7] Ibid.
 [8] Ibid.
 [9] Ibid. p.22
               
				
				
				Part 8 
				February 22, 2013     
				In the course of the
				recent article 
				series I have written 
				regarding Codex Alimentarius and its position on 
				Genetically Modified (GM) food, I have criticized both the “risk 
				assessment” method of GM food evaluation as well as 
				the official position of Codex Alimentarius in regards to the 
				“substantial equivalence” standards.    
				I have also written about the very 
				real possibility of the introduction of 
				new allergens and antibiotic resistant 
				bacteria into the general food supply.
 However, up to this point, all of the problems with the Codex 
				Guidelines mentioned have been in relation to the section of the 
				Codex GM position 
				document known as “Foods Derived From Modern Biotechnology,” 
				which focuses on GM plants.
 
 There are, accordingly, two more sections - one dealing with GM 
				Micro-Organisms and the other dealing with GM animals.
 
 However, while it may seem that the majority of criticism 
				expressed thus far focuses more attention on the first section 
				(GM plants), the fact is that all three sections are very 
				similar in their language and directives, with only a few 
				changes in the wording made to apply to the new topic.
 
				In many of these sections the language is word for word, copied 
				and pasted to reiterate the same purpose as the first section. 
				Therefore, I will not repeat my criticisms of the second and 
				third sections that have appeared in my criticism of the GM 
				Plants section.
   
				Suffice to say that all of the 
				problems existing in the GM Plant section exist in the GM 
				Micro-Organism and GM Animal sections as well, namely those of 
				questionable scientific practices, the ignoring of relevant 
				data, and so on. This claim is easily verifiable by reading the 
				Guidelines document cited in the footnotes.
 With that said, some attention should be paid to the section 
				entitled, “Guideline For The Conduct Of Food Safety Assessment 
				Of Foods Produced Using Recombinant-DNA Micro-Organisms.”
   
				This section deals mainly with 
				bacteria, yeasts, and certain types of fungi in their uses in 
				food production. 
 While making many of the same admissions present in the GM plant 
				Guidelines, one of the most startling statements made regarding 
				GM micro-organisms is the admission that they can in fact 
				survive digestion.
 
 Codex says,
 
					
					“In some processed foods, they 
					[GM micro-organisms] can survive processing and ingestion 
					and can compete and, in some cases, be retained in the 
					intestinal environment for significant periods of time.”[1] 
				While this statement is not 
				revolutionary, it is quite surprising to see it uttered by Codex 
				Alimentarius, an organization that seems to go to great lengths 
				to approve GM products.
 Nevertheless, the fact that these micro-organisms can survive 
				digestion is extremely important to the GMO safety debate. So 
				are the questions of rDNA retention in the intestinal tract, the 
				potential for changing the intestinal flora of those consuming 
				the GM product, and the subsequent effects on the immune system.
 
 These are all concerns that Codex tacitly admits the existence 
				of, simply by acknowledging the need to test them.[2]
   
				Yet the tendency of GM 
				micro-organisms to survive digestion and begin to change the 
				makeup of the human intestines is mentioned later, in a 
				footnote, where it is stated quite openly, 
					
					Permanent life-long colonization 
					by ingested micro-organisms is rare. Some orally 
					administered micro-organisms have been recovered in feces or 
					in the colonic mucosa weeks after feeding ceased. 
					   
					Whether the genetically modified 
					micro-organism is established in the gastrointestinal tract 
					or not, the possibility remains that it might influence the 
					microflora or the mammalian host.[3] 
				It should be noted that the idea 
				that “life-long colonization by ingested micro-organisms is 
				rare”[4] is highly contested by many independent 
				scientists.[5]    
				Yet, even if one were to assume the 
				truth of Codex’s statement, the fact that it is rare means that 
				it is still possible. More importantly, the statement admits 
				that, even without long-term residence in the intestinal tract, 
				there is still the distinct possibility that it will still 
				significantly affect the intestinal flora and likewise the host 
				itself.
 Still more obviously biased concerns exist in the subsection 
				dealing with the information that should be provided on each of 
				the DNA modifications or micro-organisms. This information is, 
				for the most part, very basic. It contains such data as which 
				genes are added, the number of insertion sites, etc.
   
				However, two sources of information 
				that are required to be included cause some concern.
 The first is the inclusion of the,
 
					
					“identification of any open 
					reading frames within inserted DNA or created by the 
					modifications to contiguous DNA in the chromosome or in a 
					plasmid, including those that could result in fusion 
					proteins.”[6] 
				The second is the, 
					
					“particular reference to any 
					sequences known to encode, or to influence the expression 
					of, potentially harmful functions.”[7] 
				Yet, both of these expressions 
				(fusion proteins and genes that express harmful functions) are 
				considered potentially dangerous even under the weak Codex 
				standards.    
				These expressions refer to the 
				ability of some proteins to fuse with other proteins of the same 
				and other species, mutating the DNA of the species, or forcing 
				it to produce potentially adverse effects. Neither of these 
				characteristics should be present in food, yet Codex mandates 
				only that they be reported, not removed, as a result of the 
				testing.    
				This appears to be a continual 
				thread of Codex’s Guidelines.
 Thus, Codex continues by saying that additional information 
				should be provided
 
					
					to demonstrate whether the 
					arrangement of the modified genetic material has been 
					conserved or whether significant rearrangements have 
					occurred after the introduction to the cell and propagation 
					of the recombinant strain to the extent needed for its use(s) 
					in food production, including those that may occur during 
					its storage according to current techniques;[8] 
				...as well as, 
					
					to demonstrate whether 
					deliberate modifications made to the amino acid sequence of 
					the expressed protein result in changes in its 
					post-translational modification or affect sites critical for 
					its structure or function;[9] 
				While reporting information related 
				to the instances above might seem like a good idea (and 
				certainly few would argue that it isn’t), simple reporting is 
				not enough.    
				Indeed, these issues, as well as the 
				others mentioned in this section of the Guidelines, are related 
				directly to the question of the stability of genetically 
				modified organisms.    
				This is mentioned briefly in this 
				section of the Guidelines, most notably in a footnote where it 
				says, 
					
					Microbial genes are more fluid 
					than those of higher eukaryotes; that is, the organisms grow 
					faster, adapt to changing environments, and are more prone 
					to change.    
					Chromosomal rearrangements are 
					common. The general genetic plasticity of micro-organisms 
					may affect recombinant DNA in micro-organisms and must be 
					considered in evaluating the stability of recombinant DNA 
					micro-organisms.[10] 
				It is clear that GM organisms are 
				often dangerously unstable.    
				Many of them carry genes that 
				overproduce a certain characteristic, cannot be turned off, or 
				simply begin to change even after it has been bonded to the new 
				strain of DNA.
 Yet, with all of these admissions by Codex as to the dangers 
				that GM micro-organisms pose to those who consume them as well 
				as the fact that GM DNA is often unpredictable, the Codex 
				Guidelines recommendations for testing suggest that these 
				micro-organisms should be assessed based upon tests conducted on 
				the conventional counterpart, not the micro-organism itself.
 
 If tests conclude that the questionable micro-organisms are 
				removed or rendered non-toxic in their individual and natural 
				states, then,
 
					
					“viability and residence of 
					micro-organisms in the alimentary system need no 
					examination.”[11] 
				Embodying the impracticality and 
				unscientific methodology of substantial equivalence in this 
				context, Codex does not take into account the various potential 
				dangers that it mentioned just a few short paragraphs previous.
 Even on the question of antibiotic resistance, Codex takes the 
				position of ignoring sound science in terms of its allowance of 
				antibiotic resistant genes to be used as recipient organisms.
   
				It says, 
					
					In general, traditional strains 
					of micro-organisms developed for food processing uses have 
					not been assessed for antibiotic resistance. Many 
					micro-organisms used in food production possess intrinsic 
					resistance to specific antibiotics.    
					Such properties need not exclude 
					such strains from consideration as recipients in 
					constructing recombinant-DNA micro-organisms.[12] 
				Although Codex does suggest that 
				transmissible antibiotic resistant genetic strains should not be 
				used, it clearly states that they should not be removed from 
				consideration for use.    
				This does little to ease the 
				concerns related to antibiotic resistance in general. This is 
				because, as mentioned earlier, any gene that is inserted into 
				another organism via genetic modification is inherently 
				unstable. Not only that, but this process creates the potential 
				to destabilize other genes as well. So the possibility still 
				exists even when not using what is considered a “transmissible” 
				gene.    
				Codex, of course, does not address 
				this issue. It merely suggests that these antibiotic resistant 
				genes not be removed from consideration as potential transfers 
				and recipients.
 The final mention of Codex’s treatment of GM micro-organisms 
				revolves around some of the testing methods used to determine 
				the potential of allergenicity – Sequence Homology and Pepsin 
				Resistance testing.
   
				With the exception of the specific 
				serum tests mentioned earlier (the more reliable form of testing 
				when adequately provided for), these are the only two methods 
				mentioned for determining potential micro-organism allergens.
 The problem with both of these methods is that they are 
				insufficiently geared to the task.
   
				By Codex’s own admission, Sequence 
				Homology only assesses, 
					
					“the extent to which a newly 
					expressed protein is similar in structure to a known 
					allergen,” not whether the protein actually is an allergen.[13] 
				But even this limited testing 
				ability is challenged by the fact that the test can only be 
				conducted by using sequences of allergens that are already known 
				and available in scientific literature and public databases.[14]
				   
				The document also says,  
					
					“There are also limitations in 
					the ability of such comparisons to detect non-contiguous 
					epitopes capable of binding themselves specifically with IgE 
					antibodies.”[15] 
				Therefore, the Pepsin Resistance 
				test is just as problematic as Sequence Homology because, as 
				Codex admits,  
					
					“a lack of resistance to pepsin 
					does not exclude that the newly expressed protein can be a 
					relevant allergen.”[16] 
				Because several food allergens have 
				demonstrated a resistance to pepsin digestion, it was conceived 
				that this method of testing would be useful for determining 
				potential food allergens.    
				However, this is obviously not the 
				case as the correlation between pepsin resistance and 
				allergenicity has not been fully investigated in its own right.[17]
 There is also the potential for Codex to use the some to ignore 
				the many, i.e. actually using pepsin resistance testing to claim 
				that if a substance has no pepsin resistance, then it is not a 
				potential allergen.
 
 In the end, the Codex position on GM Micro-Organisms and the 
				potential safety implications of these organisms is yet more 
				example of Codex’s complete and intentional obfuscation of the 
				relevant scientific data. In cases where the science supports 
				Codex’s position, the science is touted at every available 
				opportunity.
   
				When it does not, the science is 
				ignored. 
				
 
   
				Notes 
					
					[1] "Foods Derived From Modern Biotechnology,” 
					2nd edition. Codex Alimentarius. P.39[2] Ibid. p.42
 [3] Ibid. p.48
 [4] Ibid.
 [5] Smith, Jeffrey. “Seeds Of Deception.” YES Books, 2003.
 [6] “Foods Derived From Modern Biotechnology,” 2nd edition. 
					Codex Alimentarius. P. 44.
 [7] Ibid. p.45
 [8] Ibid. p.45
 [9] Ibid. p.45
 [10] Ibid.
 [11] Ibid p.49
 [12] Ibid. p.49
 [13] Ibid. p.53
 [14] Ibid. p.54
 [15] Ibid. p.54
 [16] Ibid. p.54
 [17] Ibid.
               
				
				
				Part 9 
				February 26, 2013     
				In my last article entitled, “Codex 
				Alimentarius and GM Food Guidelines Pt.8”, I detailed 
				the Codex Alimentarius position regarding Genetically Modified 
				(GM) Micro-Organisms. Similarly, in 
				several of the articles I have 
				written recently, I have also discussed the Codex position on
				GM plants and 
				other GM organisms.
 Yet, no analysis of the Codex Alimentarius positions on GM food 
				and/or organisms would be complete without a discussion of the 
				Codex position on GM animals.
 
 Indeed, the “Guideline For The Conduct of Food Safety Assessment 
				of Foods Derived From Recombinant-DNA Animals,” a subsection of 
				the Codex document “Foods Derived From Modern Biotechnology,” 
				is as interesting for the concerns that it does not address as 
				for the ones that it does.
   
				Largely a copied and pasted version 
				of the two sections before it, (“Guideline for the conduct of 
				food safety assessment of foods derived from recombinant-dna 
				plants” and “Guideline for the Conduct of Food safety Assessment 
				of foods produced using recombinant-dna micro-organisms”) the GM 
				animal Guidelines does not address some very key issues such as: 
					
						
						
						Animal welfare
						
						Ethical, moral and 
						socio-economic aspects
						
						Environmental risks related 
						to the environmental release of recombinant-DNA animals 
						used in food production
						
						The safety of 
						recombinant-DNA animals used as feed, or the safety of 
						animals fed with feed derived from recombinant-DNA 
						animals, plants and micro-organisms.[1] 
				As can be easily seen, these issues 
				are extremely important in their own right. Just the moral 
				issues, in addition to the hazards of the potential of GM 
				animals being released into the environment, are enough to fill 
				volumes. However, Codex chooses not to deal with these issues in 
				its Guidelines.    
				With that being said, because Codex 
				treats GM animals essentially the same as GM plants, there is 
				very little difference in the guidelines. This shows a lack of 
				scientific zeal as animals are fundamentally different than 
				plants.
 Yet one area where Codex does address a different aspect of the 
				GM safety question is related to veterinary drug residues. It 
				says,
 
					
					Some recombinant-DNA animals may 
					exhibit traits that may result in the potential for altered 
					accumulation or distribution of xenobiotics (e.g. veterinary 
					drug residues, metals), which may affect food safety. 
					   
					Similarly, the potential for 
					altered colonization by and shedding of human pathogens or 
					new symbiosis with toxin-producing organisms in the 
					recombinant-DNA animal could have an effect on food safety.[2] 
				With its implicit admission of the 
				instability of modified genes, Codex now also admits that these 
				genes, when changed in animals, could affect the distribution 
				and retention of veterinary drugs and other substances which 
				would necessarily change the content of the food product derived 
				from that animal.    
				As Codex states, this same situation 
				could also apply to human pathogens as well as veterinary drugs.
 As a side note, it appears that 2007-2008 was a very beneficial 
				year for GMO food producers. Not only were the pro-GM testing 
				Guidelines approved by Codex, but many countries, such as the 
				European Union who had been opposed to the introduction of GM 
				food up to this point, began changing their position to one that 
				was slightly more open to GMO.
 
 For instance, in 2008, Codex Alimentarius approved Guidelines 
				that would allow low levels of GM products that have not been 
				approved by the countries’ regulatory agencies inside products 
				that are imported into the country.
   
				This would include products like 
				grain, corn, and oats. Codex claims that this set of standards 
				merely recognizes the fact that GM products will inadvertently 
				mix with non-GM products during processing and transportation 
				and that it means to provide guidance in this unavoidable 
				situation.[3]
 However, this presupposes that GM contamination of food 
				shipments is unavoidable when in fact just the opposite is the 
				case. If GM products were not used to begin with, the entire 
				issue would not need to be addressed.
 
 Also, if countries that did not approve of GM products would 
				simply refuse to import them if they were contaminated with one 
				single GM organism, then the fact that the majority of people do 
				not want GM food would be driven home.
   
				This would be a great move for both 
				the exporting and importing countries in that GM would be made 
				economically unfeasible as well as forcing the importing country 
				to produce their own food.    
				It may come as a surprise to many 
				that these Guidelines were approved with the consent of the 
				European Union, the very state that has voiced much dissent to 
				GM products in the past. This is a clear signal that the 
				European Union, now that is has become even more integrated than 
				it was when the GM debate first appeared, is preparing to accept 
				GM food on the level of the United States in the future.
 While these Guidelines only apply to GM contamination of 
				imported food, the European Union’s own guidelines have become 
				much more relaxed in relation to GM food production within its 
				borders. It is here that the various European countries are 
				experiencing the tyranny of being a member of a European 
				super-state that undermines their national sovereignty.
 
 In March 2010, against the objections of countries such as Italy 
				and Austria, the European Union’s European Commission approved 
				an antibiotic resistant genetically modified potato.[4]
 
 These countries who, before joining the EU, would have had 
				complete authority to block the importation and production of GM 
				material now must defer to the EU court and commission system 
				that are clearly undemocratic and unconcerned with the safety of 
				the European people.
 
 This is the same situation that occurred in 1998 when the 
				European Union approved the MON810 strain of GM maize developed 
				by Monsanto against the protest of several EU states.
 
 Subsequently, several member nations banned the cultivation of 
				the maize which now pits them against the European Commission in 
				an ongoing battle for national sovereignty.[5]
 
 However, sovereignty is not likely to win out.
 
 In 2007, the European Court of Justice overturned Austria’s ban 
				on cultivation of GMO’s even though Austria has the broad 
				support of its people and other nations.
 
 The court also ruled that individual countries had no right to 
				deny farmers the ability to grow GM crops that the EU had 
				previously approved. This ruling has effectively removed 
				Austria’s total cultivation ban. While many other Austrian 
				regulations are in place that will make it a little more 
				difficult for GMO production than in other countries, the 
				European Commission and Courts will likely continue to chip away 
				at them little by little.[6]
 
 India has also relaxed its opposition to GM foods as evidenced, 
				also in 2007, by the fact that the Indian Ministry of 
				Environment and Forests announced that organisms that are not 
				living (living being defined as an organism capable of 
				replication) will now be exempt from the existing approval 
				processes. This effectively allowed all “non-living organisms” 
				into India without any testing at all.
   
				This applied to a wide range of 
				products such as those containing GM corn or soy.[7]
 It should also be mentioned that as of January 2009, the FDA has 
				announced that labeling of GM food animals is not required at 
				the consumer level.
 
 While GM animals are required to be labeled while alive, when 
				the animals reach the food stage, the labeling requirements 
				disappear. GM animals are only required to be labeled at the 
				food stage when there appears to be a substantial difference in 
				the food product.[8]
 
 However, it should be remembered that, because the FDA works on 
				an even more relaxed version of substantial equivalence than 
				Codex, it is already assumed that these foods will not be 
				significantly different from a conventional counterpart.
 
 Thus, we have unfettered access of GM animal food products to 
				the food supply with no way for the consumer to determine 
				whether or not the product he/she is eating has been genetically 
				modified - a step which the FDA and Codex Alimentarius have both 
				worked so hard to reach in the past.
   
				
 
				Notes
 
					
					[1] “Foods Derived From Modern Biotechnology,” 
					2nd edition. Codex Alimentarius. P. 57. [2] Ibid. p.71
 [3] “Codex 
					Alimentarius Commission: New Standards, old concerns,” 
					July 14, 2008.
 [4] Hickman, Martin; Roberts, Genevieve. “Fury 
					as EU approves GM potato.” The Independent. March 
					4, 2010.
 [5] “EU 
					food authorities say genetically modified maize is safe.” 
					AFP. June 30, 2009. Accessed May 24, 2010.
 [6] “Further 
					‘Rubberstamp’ GMO Approvals In The Pipeline In Europe.” 
					Bridges Trade BioRes October 5, 2007. Vol. 7 No. 17.  
					Accessed May 24, 2010.
 [7] “India 
					Fast-Tracks Imports Of Non-Living GM Material.” Bridges 
					Trade BioRes October 5, 2007. Vol. 7 No. 17.  Accessed 
					May 24, 2010.
 [8] Reinberg, Steven. “FDA 
					Issues Final Regulations for Geneticially Engineered Animals.” 
					US News And World Report. January 15, 2009.  Accessed 
					May 24, 2010.
   
			  |